anti- alpha 1 Antichymotrypsin / AACT antibody

Uncover the mysteries of protease inhibition with our specialized Anti-Alpha 1 Antichymotrypsin (AACT) Antibody, now available in a convenient 100µg size. AACT is a critical protease inhibitor that regulates the activity of chymotrypsin and other proteases. Our meticulously crafted antibody offers exceptional specificity and sensitivity, making it the perfect choice for a wide range of applications, from protease research to immunohistochemistry.

What truly distinguishes our Anti-Alpha 1 Antichymotrypsin Antibody is its exceptional performance. It has undergone rigorous testing and validation to ensure reliable and reproducible results, effectively reducing experimental variability and saving valuable time and resources.

With a generous 100µg size, this product provides an ideal balance between cost-effectiveness and practicality, offering ample antibody for multiple experiments while minimizing wastage, aligning with our commitment to sustainable research practices.

Engineered for user-friendliness, our Anti-Alpha 1 Antichymotrypsin Antibody is suitable for researchers at all levels, whether you're a novice or an experienced scientist. It seamlessly integrates into various laboratory techniques, enhancing the precision and reliability of your experiments.

Empower your research with confidence, knowing you have the support of a high-quality, meticulously crafted Anti-Alpha 1 Antichymotrypsin (AACT) Antibody. Dive into the captivating world of protease biology and contribute to groundbreaking insights in the field.

Product Name

alpha 1 Antichymotrypsin / AACT antibody

Size

100µg

Form

liquid

Purification

Immunogen affinity purified

Purity

≥95% as determined by SDS-PAGE

Host

Rabbit

Clonality

polyclonal

Isotype

IgG

Storage

PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months (Avoid repeated freeze / thaw cycles.)

BACKGROUND

The protein encoded by this gene is a plasma protease inhibitor and member of the serine protease inhibitor class. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein's sequence have been implicated in Alzheimer's disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease.

IMMUNOGEN INFORMATION

Immunogen

serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3

Synonyms

A1 Antichymotrypsin, AACT, ACT, Alpha 1 antichymotrypsin, GIG24, GIG25, Serpin A3, SERPINA3

Observed MW

50 kDa

APPLICATION

Tested Application

ELISA, IHC, WB, IF

Recommended Dilution

WB: 1:500 - 1:2000; IHC: 1:50 - 1:100; IF: 1:50 - 1:200

UNIPROT INFORMATION

UniProt ID

P01011

IMAGES